ISOLATION AND CHARACTERIZATION OF A CHINESE-HAMSTER OVARY CELL MUTANTWITH IMPROVED STAINING FOR INDO-1

Authors
Citation
Ed. Wieder et Mh. Fox, ISOLATION AND CHARACTERIZATION OF A CHINESE-HAMSTER OVARY CELL MUTANTWITH IMPROVED STAINING FOR INDO-1, Cytometry, 17(1), 1994, pp. 33-38
Citations number
25
Categorie Soggetti
Cytology & Histology","Biochemical Research Methods
Journal title
ISSN journal
01964763
Volume
17
Issue
1
Year of publication
1994
Pages
33 - 38
Database
ISI
SICI code
0196-4763(1994)17:1<33:IACOAC>2.0.ZU;2-R
Abstract
Chinese hamster ovary (CHO) 10B2 cells do not stain well with indo-1 a nd thus cannot be used for experiments to measure intracellular calciu m using this dye. We have isolated a mutant CHO cell line (CHO IS1) th at stains quite well with indo-1 and that has virtually identical grow th characteristics and heat sensitivity as the parent line. The mutant was isolated by sorting individual mutagenized cells with high indo-1 fluorescence and cloning them. Since it has been reported that cells with multiple drug resistance (MDR(+)) can pump out various fluorescen t dyes, the mutant and parent lines were characterized for Hoechst 333 42 staining, Adriamycin toxicity, and P-glycoprotein expression, which are markers of the MDR phenotype. P-Glycoprotein was measured with th e C219 antibody using flow cytometry. Multidrug-resistant cells (CH(R) C5) were used as positive controls. The IS1 cells stained as well with Hoechst 33342 as fixed 10B2 cells, and much better than unfixed 10B2 cells. The IS1 cells were 10- to 30-fold more sensitive to Adriamycin than the 10B2 cells, and both cell lines were much more sensitive than the CH(R)C5 cells. The amount of P-glycoprotein was similar in both 1 0B2 and IS1 cell lines, but was about fivefold lower than the CH(R)C5 cells. Thus, the poor staining for indo-1 in the 10B2 cells may not be caused by the P-glycoprotein MDR pump, but by a different efflux path way. Alternatively, the P-glycoprotein may be altered and less efficie nt in the CHO IS1 cells. (C) 1994 Wiley-Liss, Inc.